275 related articles for article (PubMed ID: 32453941)
21. Biochemical and structural analysis of N-myristoyltransferase mediated protein tagging.
Monassa P; Rivière F; Dian C; Frottin F; Giglione C; Meinnel T
Methods Enzymol; 2023; 684():135-166. PubMed ID: 37230587
[TBL] [Abstract][Full Text] [Related]
22. Mammalian myristoyl CoA: protein N-myristoyltransferase.
Raju RV; Magnuson BA; Sharma RK
Mol Cell Biochem; 1995; 149-150():191-202. PubMed ID: 8569729
[TBL] [Abstract][Full Text] [Related]
23. Roles of Protein N-Myristoylation and Translational Medicine Applications.
Xu M; Xie L; Yu Z; Xie J
Crit Rev Eukaryot Gene Expr; 2015; 25(3):259-68. PubMed ID: 26558949
[TBL] [Abstract][Full Text] [Related]
24. Myristoyltransferase and calcineurin: novel molecular therapeutic target for epilepsy.
Lakshmikuttyamma A; Selvakumar P; Tuchek J; Sharma RK
Prog Neurobiol; 2008 Jan; 84(1):77-84. PubMed ID: 17997006
[TBL] [Abstract][Full Text] [Related]
25. Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs.
Bhatnagar RS; Fütterer K; Farazi TA; Korolev S; Murray CL; Jackson-Machelski E; Gokel GW; Gordon JI; Waksman G
Nat Struct Biol; 1998 Dec; 5(12):1091-7. PubMed ID: 9846880
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation and dephosphorylation of human myristoyltransferase type 1.
Selvakumar P; Sharma RK
Can J Physiol Pharmacol; 2006 Jul; 84(7):707-12. PubMed ID: 16998534
[TBL] [Abstract][Full Text] [Related]
27. Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors.
Schlott AC; Mayclin S; Reers AR; Coburn-Flynn O; Bell AS; Green J; Knuepfer E; Charter D; Bonnert R; Campo B; Burrows J; Lyons-Abbott S; Staker BL; Chung CW; Myler PJ; Fidock DA; Tate EW; Holder AA
Cell Chem Biol; 2019 Jul; 26(7):991-1000.e7. PubMed ID: 31080074
[TBL] [Abstract][Full Text] [Related]
28. Regulation of N-myristoyltransferase by novel inhibitor proteins.
Shrivastav A; Selvakumar P; Bajaj G; Lu Y; Dimmock JR; Sharma RK
Cell Biochem Biophys; 2005; 43(1):189-202. PubMed ID: 16043893
[TBL] [Abstract][Full Text] [Related]
29. Potential role of N-myristoyltransferase in cancer.
Selvakumar P; Lakshmikuttyamma A; Shrivastav A; Das SB; Dimmock JR; Sharma RK
Prog Lipid Res; 2007 Jan; 46(1):1-36. PubMed ID: 16846646
[TBL] [Abstract][Full Text] [Related]
30. Expression, localization, and correlation of N-myristoyltransferase and its inhibitor in bovine eye.
Shrivastav A; Pasha MK; Selvakumar P; Singh B; Sharma RK
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1674-9. PubMed ID: 15161825
[TBL] [Abstract][Full Text] [Related]
31. A fluorescence-based assay for N-myristoyltransferase activity.
Goncalves V; Brannigan JA; Thinon E; Olaleye TO; Serwa R; Lanzarone S; Wilkinson AJ; Tate EW; Leatherbarrow RJ
Anal Biochem; 2012 Feb; 421(1):342-4. PubMed ID: 22051857
[TBL] [Abstract][Full Text] [Related]
32. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
Raju RV; Datla RS; Warrington RC; Sharma RK
Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
[TBL] [Abstract][Full Text] [Related]
33. Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.
Shrivastav A; Sharma AR; Bajaj G; Charavaryamath C; Ezzat W; Spafford P; Gore-Hickman R; Singh B; Copete MA; Sharma RK
Oncol Rep; 2007 Jul; 18(1):93-7. PubMed ID: 17549352
[TBL] [Abstract][Full Text] [Related]
34. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
[TBL] [Abstract][Full Text] [Related]
35. Myristoyl CoA:protein N-myristoyltransferase: subcellular localization, activation and kinetic behavior in the presence of organic solvents.
Rajala RV; Sharma RK
Biochem Biophys Res Commun; 1995 Mar; 208(2):617-23. PubMed ID: 7695615
[TBL] [Abstract][Full Text] [Related]
36. Structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoylCoA and peptide provide insights about substrate recognition and catalysis.
Farazi TA; Waksman G; Gordon JI
Biochemistry; 2001 May; 40(21):6335-43. PubMed ID: 11371195
[TBL] [Abstract][Full Text] [Related]
37. Novel fatty acyl substrates for myristoyl-CoA:protein N-myristoyl-transferase.
Heuckeroth RO; Jackson-Machelski E; Adams SP; Kishore NS; Huhn M; Katoh A; Lu T; Gokel GW; Gordon JI
J Lipid Res; 1990 Jun; 31(6):1121-9. PubMed ID: 2197361
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of multiple forms of bovine brain N-myristoyltransferase.
Glover CJ; Felsted RL
J Biol Chem; 1995 Sep; 270(39):23226-33. PubMed ID: 7559471
[TBL] [Abstract][Full Text] [Related]
39. N-myristoyltransferase: a novel target.
Prasad KK; Toraskar MP; Kadam VJ
Mini Rev Med Chem; 2008 Feb; 8(2):142-9. PubMed ID: 18289097
[TBL] [Abstract][Full Text] [Related]
40. Heteroatom-substituted fatty acid analogs as substrates for N-myristoyltransferase: an approach for studying both the enzymology and function of protein acylation.
Heuckeroth RO; Glaser L; Gordon JI
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8795-9. PubMed ID: 3143109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
